News

McNeil Consumer Healthcare informed Health Canada that they are taking this action following consumer reports of foreign materials in the product, including metal and wood particles. McNeil is

In each case, the filing of the application will initiate an undisclosed milestone payment to MorphoSys. The therapeutic antibodies are being developed in the therapeutic areas of cancer

Administered every six months as a convenient subcutaneous injection, Denosumab reduces the risk of fractures at the spine, hip and other key non-vertebral sites. Amgen and GSK said

Following the launch Inspire will receive a related milestone payment of $1.25m in the fourth quarter of 2010 and is also entitled to receive payments based upon a

In a regulatory filing Pfizer disclosed that Kindler will get an exit package that includes: $3.25m in cash bonus, a $1.8m cash ‘short-term incentive shift award,’ cash severance

Accovion provides study planning and management, clinical monitoring, pharmacovigilance including post-marketing safety, data management, biostatistics, statistical programming, medical writing and electronic publishing. Accovion chief operating officer Ivana Waller

Under the terms of the agreement, GSK will acquire Maxinutrition’s brands, including Maximuscle. GSK said the deal will extend its reach into wider categories, complementing its existing Nutritional

Teva‘s requests in this CP are based on the inability to establish acceptable ‘sameness’ of the active ingredients in glatiramer acetate, the complexity of the mechanism of action

Serodus has in-licensed RO1160367, a drug candidate ready to enter a clinical Phase II Proof-of-Concept study in heart failure. Under the Agreement, Serodus will receive the full preclinical